CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.20 0.35(1.17%) NAV as on 23 Apr 2025
1.58 % 1 M
16.92 % 1 Y
18.35 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.34

As on 31 Mar, 2025
age-icon Age :

5 yrs 9 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

814.95 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.39

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 1.21 %
Equity 98.79 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.61 %
Cipla Ltd.8.44 %
Torrent Pharmaceuticals Ltd.7.05 %
Apollo Hospitals Enterprise Ltd.6.90 %
Abbott India Ltd.6.14 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs79.07
Hospital & Healthcare Services17.50
Business Support1.46
Chemicals0.76
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)16.1218.2216.3626.4529.39
Net Assets(Rs Crores) (as on 31-Mar-2025) 454.91 515.33 428.44 699.55 814.95
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.03
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9032/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.200.35(1.17%)NAV As on 23 Apr, 202510-Jul-2019Inception Date814.95AUM In Cr.16.92%1Y18.35%3Y20.12%5Y21.03%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.570.50(1.35%)NAV As on 23 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.24.40%1Y23.98%3Y25.65%5Y21.55%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.773.97(0.95%)NAV As on 23 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.24.04%1Y23.61%3Y25.30%5Y16.36%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.620.35(1.19%)NAV As on 23 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.20.10%1Y20.07%3Y22.33%5Y12.35%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors